BPC-157 (body protection compound), is an endogenous, stable pentadecapeptide 15 amino acids first derived from gastric juices
Hampel H, Hardy J, Blennow K et al (2021) The amyloid- pathway in alzheimers disease
For the laboratory researcher, the two peptides remain interesting tools provided they are used for what they truly are: compounds research use only With a robust but asymmetrical preclinical literature (35 AJSM 2026 studies for BPC-157, muscle/cardiac base for TB-500), and extremely limited human data on both sides, maintaining this nuance helps avoid claims not supported by science and properly position the two peptides within a well-designed research protocol
For clinicians and patients building a precision longevity protocol, the central question is no longer whether MOTS-c matters, but how to dose it correctly
Through their ability to stabilize actin filaments, modulate fibroblast migration, and enhance microvascular development, thymosin beta-4 and TB-500 each appear to support processes that accelerate cellular recovery following injury
For acute injuries, the traditional RICE protocol (rest, ice, compression, elevation) emphasizes immediate cold application during the first 48 hours when inflammatory processes are most active